
Gardasil significantly increases ISI in RRP patients over 45. In this expanded cohort study (51 patients, 14 vaccinated), ISI rose from 126 to 304 days post-vaccination (p=0.0039). However, ISI declined from 494 days in prior research, suggesting a potential waning effect over time. Non-Gardasil adjuvants had no significant impact. Findings support Gardasil’s durability but highlight the need to explore booster dosing for sustained benefits.
Like
Save
Share